Wednesday, February 26, 2020

Vaccine Papers: Al Adjuvant Causes Brain Inflammation and Behavioral Abnormalities

Al Adjuvant Causes Brain Inflammation and Behavioral Abnormalities; Low Dose Is More Harmful

Excerpt:

A new paper (Crepeaux et al.) by the Gherardi research group in France reports important results on the toxicity and transport of aluminum (Al) adjuvant in mice. This study is especially valuable because it looked at many outcomes: behavioral effects, immune (microglial) activation in the brain, and Al transport into the brain. The study tested dosages of 200 , 400 and 800 mcg/Kg (mcg=micrograms, mcg/Kg = micrograms per kilogram of animal body weight),  injected intramuscularly (IM). The Al adjuvant used was AlOH (brand name Alhydrogel), the most common vaccine adjuvant. It is in the tetanus, Hep A, Hep B, HiB, pneumococcal, meningococcal, and anthrax vaccines.
Remarkably, the study  found that the lowest dosage (200 mcg/Kg) was the most toxic! The 400 and 800 mcg/Kg dosages produced no statistically significant effects, but the 200 mcg/Kg dosage did.
Compare these dosages with dosages given to human infants according to the CDCs vaccine schedule in the first 6 months:
Birth (Hep B):   74 mcg/kg (250 mcg for 3.4 kg infant)
2 month:           245 mcg/kg (1225 mcg for 5 kg infant)
4 month:           150 mcg/kg (975 mcg for 6.5 kg infant)
6 month:           153 mcg/kg (1225 mcg for 8 kg infant)
...

Behavioral Effects
Significant differences in behavior were observed in open field tests in the 200 mcg/Kg group, but not in the higher dosage or control groups.


Read: Al Adjuvant Causes Brain Inflammation and Behavioral Abnormalities; Low Dose Is More Harmful


No comments:

Post a Comment